LC-MS-MS analysis of dietary supplements for N-ethyl-α-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine

Journal of Analytical Toxicology

Volumn 38, Issue 2, 2014, Pages 63-72

  ElSohly, Mahmoud A ^a,b,c   Gul, Waseem ^a,b  

^a ElSohly Laboratories Incorporated   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLAMINES; CALIBRATION; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; DOPING IN SPORTS; HUMANS; LIMIT OF DETECTION; MAGNETIC RESONANCE SPECTROSCOPY; PERFORMANCE-ENHANCING SUBSTANCES; PHENETHYLAMINES; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84894063452     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt097     Document Type: Article

References (11)

1. Glen, R., Hanson, P.J., Venturelli, A., Fleckenstein, E. (2005) Drugs and Society. 9th edition. Jones and Bartlett Publishers: Sudbury, MA. ISBN 978-0-7637-3732-0 Retrieved 2011-04-19.
2. Sabelli, H.C., Mosnaim, A.D., Vazquez, A.J., Giardina, W.J., Borison, R.L., Pedemonte,W.A. (1976) Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle. Biological Psychiatry, 11, 481-524.
3. Nakamura, M., Ishii, A., Nakahara, D. (1998) Characterization of b-phenylethylamine-inducedmonoamine release in rat nucleus accumbens: a microdialysis study. European Journal of Pharmacology, 349, 163-169. doi:10.1016/S0014-2999(98)00191-5.
4. Parker, E.M., Cubeddu, L.X. (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. Journal of Pharmacology and Experimental Therapeutics, 245, 199-210. ISSN 0022-3565.
5. Paterson, I.A. (1993) The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline. Neurochemical Research, 18, 1329-1336. doi:10.1007/BF00975055.
6. Shulgin, A., Shulgin, A. Erowid Online Books: 'PIHKAL' - #142 PEA. Transform Press: Berkeley, CA. (13 May 2010, date last accessed).
7. Baker, G.B., Bornstein, R.A., Rouget, A.C., Ashton, S.E., van Muyden, J.C., Coutts, R.T. (1991) Phenylethylaminergic mechanisms in attentiondeficit disorder. Biological Psychiatry, 29, 15-22. doi:10.1016/0006-3223(91)90207-3.
8. Potkin, S.G. et al. (1979) Phenylethylamine in paranoid chronic schizophrenia. Science, 206, 470-471. doi:10.1126/science.504988.
9. Lands, A.M., Grant, J.I. (1952) The vasopressor action and toxicity of cyclohexylethylamine derivatives. Journal of Pharmacology and Experimental Therapeutics, 106, 341-345.
10. Lee, J., Choe, S., Choi, H., Heo, S., Kim, E., Kim, H. et al. (2013) Identification of N-ethyl-a-ethyphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug? Forensic Toxicology, 31, 54-58. doi:10.1007SKim11419- Kim012-0158-1
11. Australian Sports Anti-Doping Authority, Sanctions. http://www.asada.gov.au/rules_and_violations/sanctions.html. (25 July 2013, date last accessed).